Idiopathis Pulmonary Fibrosis, Emphysema and other lung diseases are just a few of the medical conditions that are long-term and are considered progressive diseases. Among other things, these diseases can shorten one's life span and can hinder the patient from enjoying various activities and experiences.
Patients who have lung diseases often complain of shortness of breath. Some may feel slightly suffocated and can not get in enough air.
Stem cell therapy have proven to help ease these difficulties in patients who have lung diseases. Stem cells that have been activated and returned back to the patient travel to the lungs, rejuvenating various parts of the respiratory system and help re-oxygenate tissues, allowing the patient to breathe in easier.
Dr Buoros of Harvard Medical School has been using stem cell therapy to treat and allow patients who have terminal stage of Idiopathic Pulmonary Fibrosis another shot at life. After receiving the treatment, patients who have emphysema have responded positively to the treatment and are showing an increase in forced volume capacity of the lungs. Smokers felt that 'they have a new lease on life' after the first stem cell therapy has been administered.